As the U.S. market navigates a landscape marked by fluctuating indices and rising Treasury yields, investors are closely watching legislative developments that could impact economic conditions. Amidst this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for those looking to capitalize on market inefficiencies. Top 10 Undervalued Stocks Based On Cash Flows In The United States Name Current Price Fair Value (Est) Discount (Est) Berkshire Hills Bancorp (NYSE:BHLB) $26.27 $51.54 49% Quaker Chemical (NYSE:KWR) $107.26 $210.06 48.9% Super Group (SGHC) (NYSE:SGHC) $8.44 $16.54 49% KBR (NYSE:KBR) $55.33 $108.40 49% Horizon Bancorp (NasdaqGS:HBNC) $15.69 $30.68 48.9% Insteel Industries (NYSE:IIIN) $36.65 $72.23 49.3% First Reliance Bancshares (OTCPK:FSRL) $9.45 $18.49 48.9% Carvana (NYSE:CVNA) $302.29 $586.89 48.5% Verra Mobility (NasdaqCM:VRRM) $24.53 $47.91 48.8% Mobileye Global (NasdaqGS:MBLY) $16.05 $31.07 48.3% Click here to see the full list of 171 stocks from our Undervalued US Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. TransMedics Group Overview: TransMedics Group, Inc. is a commercial-stage medical technology company focused on transforming organ transplant therapy for end-stage organ failure patients globally, with a market cap of $4.13 billion. Operations: The company's revenue is primarily derived from its Surgical & Medical Equipment segment, which generated $488.23 million. Estimated Discount To Fair Value: 47.9% TransMedics Group is trading at US$124.71, significantly below its estimated fair value of US$239.19, suggesting it may be undervalued based on cash flows. Recent earnings showed strong growth with Q1 2025 revenue at US$143.54 million and net income of US$25.68 million, reflecting improved profitability. The company's revised full-year revenue guidance projects up to $585 million, indicating robust future growth potential despite debt concerns not fully covered by operating cash flow. The growth report we've compiled suggests that TransMedics Group's future prospects could be on the up. Click here to discover the nuances of TransMedics Group with our detailed financial health report.NasdaqGM:TMDX Discounted Cash Flow as at May 2025 Willdan Group Overview: Willdan Group, Inc. offers professional, technical, and consulting services mainly in the United States and has a market cap of $731.80 million. Operations: The company's revenue is derived from two main segments: Energy, contributing $498.81 million, and Engineering & Consulting, accounting for $96.88 million. Estimated Discount To Fair Value: 14.9% Story Continues Willdan Group, trading at US$50.55, is undervalued based on cash flows with an estimated fair value of US$59.43. Earnings are expected to grow significantly at 23.4% annually, outpacing the broader US market. Recent Q1 2025 results showed a revenue increase to US$152.39 million and net income of US$4.69 million, reflecting ongoing profitability improvements amid strategic acquisitions and expanded credit facilities enhancing financial flexibility for future growth initiatives. Our comprehensive growth report raises the possibility that Willdan Group is poised for substantial financial growth. Dive into the specifics of Willdan Group here with our thorough financial health report.NasdaqGM:WLDN Discounted Cash Flow as at May 2025 Grindr Overview: Grindr Inc. operates a social networking and dating application catering to the LGBTQ community globally, with a market cap of $4.66 billion. Operations: The company's revenue primarily comes from its Internet Information Providers segment, generating $363.23 million. Estimated Discount To Fair Value: 31.4% Grindr, trading at US$24.31, is significantly undervalued with a fair value estimate of US$35.45. The company reported Q1 2025 sales of US$93.94 million and net income of US$27.02 million, reversing a previous loss, alongside raised full-year revenue growth guidance to 26% or more. Despite insider selling and profitability expected within three years, Grindr's strategic expansions and share buyback program underscore its potential for enhanced cash flow valuation. According our earnings growth report, there's an indication that Grindr might be ready to expand. Take a closer look at Grindr's balance sheet health here in our report.NYSE:GRND Discounted Cash Flow as at May 2025 Make It Happen Unlock more gems! Our Undervalued US Stocks Based On Cash Flows screener has unearthed 168 more companies for you to explore.Click here to unveil our expertly curated list of 171 Undervalued US Stocks Based On Cash Flows. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Searching for a Fresh Perspective? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGM:TMDXNasdaqGM:WLDN and NYSE:GRND. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Assessing TransMedics Group And Two Other Stocks That Might Be Trading Below Estimated Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...